Quality of life in XXXX with esophageal stenting for the palliation of @entity5 .

@entity1 @entity514 @entity5 @entity1702 @entity418 @entity1282
Incidence of @entity418 ( @entity418 ) is rising more rapidly in the Western world than that of any other @entity5 . Despite advances in therapy, more than 50% of @entity1 have incurable disease at the time of presentation. This precludes curative treatment and makes palliative treatment a more realistic option for most of these @entity1 . @entity1282 is the predominant symptom in more than 70% of @entity1 with @entity418 and although several management options have been developed in recent years to palliate this symptom, the optimum management is not established. @entity1702 ( @entity1702 ) are a well-established palliation modality for @entity1282 in such @entity1 . Health-related quality of life (HRQoL) is becoming a major issue in the evaluation of any therapeutic or palliative intervention. To date, only a few published studies can be found on Medline examining HRQoL in @entity1 with advanced @entity418 treated with @entity1702 implantation. The aim of this study was to review the impact on HRQoL of @entity1702 implantation as palliative treatment in @entity1 with @entity418 . All Medline articles regarding HRQoL in @entity1 with advanced @entity418 , particularly those related to @entity1702 , were reviewed. In most studies, relief of @entity1282 was the only aspect of HRQoL being measured and @entity1702 implantation was compared with other palliative treatments such as brachytherapy and laser therapy. @entity1702 insertion provides a @entity514 palliation of @entity1282 compared to brachytherapy and no evidence was found to suggest that stent implantation is different to laser treatment in terms of improving @entity1282 , recurrent @entity1282 and better HRQoL, although @entity1702 insertion has a better technical success rate and also reduces the number of repeat interventions.
